Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015
November 10, 2022
Preclinical Data from Aptinyx’s NMDA Receptor Modulators to be Presented at the 52nd Annual Meeting of the Society for Neuroscience
Download PDF format download (opens in new window)
November 08, 2022
Aptinyx Reports Third Quarter 2022 Financial Results and Recent Highlights
Download PDF format download (opens in new window)
November 03, 2022
Clinical Evaluation of Aptinyx's NYX-783 for Treatment of Opioid Use Disorder to Be Funded by $5.6 Million NIH Grant
Download PDF format download (opens in new window)
October 18, 2022
Aptinyx to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
Download PDF format download (opens in new window)
August 25, 2022
Aptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson’s Disease and Dementia with Lewy Bodies
Download PDF format download (opens in new window)
August 12, 2022
Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Fibromyalgia
Download PDF format download (opens in new window)
August 04, 2022
Aptinyx Reports Second Quarter 2022 Financial Results and Recent Highlights
Download PDF format download (opens in new window)
July 15, 2022
Aptinyx to Report Second Quarter 2022 Financial Results on Thursday, August 4, 2022
Download PDF format download (opens in new window)
June 22, 2022
Aptinyx to Participate in H.C. Wainwright 1st Annual Mental Health Conference
Download PDF format download (opens in new window)
May 18, 2022
Aptinyx to Participate in H.C. Wainwright Global Investment Conference
Download PDF format download (opens in new window)
May 17, 2022
Aptinyx Announces Poster Presentation Highlighting Preclinical Data on NYX-783 in Models of PTSD at the 2022 American Psychiatric Association Annual Meeting
Download PDF format download (opens in new window)
May 12, 2022
Aptinyx Reports First Quarter 2022 Financial Results and Highlights Recent Clinical Progress
Download PDF format download (opens in new window)
April 29, 2022
Aptinyx Presents Preclinical Data on NYX-783 in Models of PTSD at 2022 Society of Biological Psychiatry Annual Meeting
Download PDF format download (opens in new window)
April 27, 2022
Aptinyx to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
Download PDF format download (opens in new window)
April 20, 2022
Aptinyx Announces Publication in Molecular Psychiatry Demonstrating Reduction of Spontaneous Recovery of Fear with NYX-783
Download PDF format download (opens in new window)
April 07, 2022
Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy
Download PDF format download (opens in new window)
March 23, 2022
Aptinyx Reports Fourth Quarter and Full Year 2021 Results and Highlights
Download PDF format download (opens in new window)
March 09, 2022
Aptinyx to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, March 23, 2022
Download PDF format download (opens in new window)
March 01, 2022
Aptinyx to Participate in the 42nd Annual Cowen Health Care Conference
Download PDF format download (opens in new window)
February 28, 2022
Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Fibromyalgia
Download PDF format download (opens in new window)
February 09, 2022
Aptinyx Hosts Virtual Portfolio Review Event to Showcase NYX-2925 in Chronic Pain and Provide Update on Clinical Development Programs
Download PDF format download (opens in new window)
February 08, 2022
Aptinyx to Present at the SVB Leerink 11th Annual Global Healthcare Conference
Download PDF format download (opens in new window)
February 03, 2022
Aptinyx Announces Formation of Scientific Advisory Board
Download PDF format download (opens in new window)
January 06, 2022
Aptinyx Highlights Key Goals and Anticipated Development Milestones for 2022
Download PDF format download (opens in new window)